BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25219592)

  • 1. Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.
    Pang YY; Wang T; Chen FY; Wu YL; Shao X; Xiao F; Huang HH; Zhong H; Zhong JH
    Leuk Lymphoma; 2015 Jun; 56(6):1821-30. PubMed ID: 25219592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
    Maher JC; Wangpaichitr M; Savaraj N; Kurtoglu M; Lampidis TJ
    Mol Cancer Ther; 2007 Feb; 6(2):732-41. PubMed ID: 17308069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
    Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
    BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.
    Broecker-Preuss M; Becher-Boveleth N; Bockisch A; Dührsen U; Müller S
    J Transl Med; 2017 Jul; 15(1):158. PubMed ID: 28724379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL.
    Hernandez-Luna MA; Rocha-Zavaleta L; Vega MI; Huerta-Yepez S
    Leuk Lymphoma; 2013 May; 54(5):1048-55. PubMed ID: 23013270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells.
    Xiao H; Li S; Zhang D; Liu T; Yu M; Wang F
    Oncol Rep; 2013 Jan; 29(1):329-34. PubMed ID: 23076497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
    Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
    World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines.
    Wangpaichitr M; Savaraj N; Maher J; Kurtoglu M; Lampidis TJ
    Mol Cancer Ther; 2008 Jun; 7(6):1506-13. PubMed ID: 18566221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolytic inhibitor 2-Deoxy-d-Glucose activates migration and invasion in glioblastoma cells through modulation of the miR-7-5p/TFF3 signaling pathway.
    Shukla A; Gupta P; Singh R; Mishra DP
    Biochem Biophys Res Commun; 2018 May; 499(4):829-835. PubMed ID: 29621542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines.
    Malm SW; Hanke NT; Gill A; Carbajal L; Baker AF
    J Exp Clin Cancer Res; 2015 Apr; 34(1):31. PubMed ID: 25888489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src.
    Guo B; Zhang Y; Hui Q; Wang H; Tao K
    Tumour Biol; 2016 Mar; 37(3):3841-50. PubMed ID: 26476533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
    Zhang T; Zhu X; Wu H; Jiang K; Zhao G; Shaukat A; Deng G; Qiu C
    J Cell Mol Med; 2019 May; 23(5):3711-3723. PubMed ID: 30920152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice.
    Huang CC; Wang SY; Lin LL; Wang PW; Chen TY; Hsu WM; Lin TK; Liou CW; Chuang JH
    Dis Model Mech; 2015 Oct; 8(10):1247-54. PubMed ID: 26398947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.
    Straus DS
    Mol Cancer; 2013 Jul; 12():78. PubMed ID: 23866118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
    Xia L; Sun J; Xie S; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Sha J; Xue W
    Cell Prolif; 2020 Nov; 53(11):e12918. PubMed ID: 33025691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromodomains and Extra-Terminal (BET) Inhibitor JQ1 Suppresses Proliferation of Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolysis.
    Zhang MY; Liu SL; Huang WL; Tang DB; Zheng WW; Zhou N; Zhou H; Abudureheman T; Tang ZH; Zhou BS; Duan CW
    Med Sci Monit; 2020 Apr; 26():e923411. PubMed ID: 32266878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α.
    Chiche J; Pommier S; Beneteau M; Mondragón L; Meynet O; Zunino B; Mouchotte A; Verhoeyen E; Guyot M; Pagès G; Mounier N; Imbert V; Colosetti P; Goncalvès D; Marchetti S; Brière J; Carles M; Thieblemont C; Ricci JE
    Leukemia; 2015 May; 29(5):1163-76. PubMed ID: 25394713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
    Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
    Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
    Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.